| Name | (8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one |
|---|---|
| Synonyms |
Ulipristal (CDB-2914)
Ulipristal, 10 mM in DMSO Ulipristal,(11beta)-11-[4- (Dimethylamino)phenyl]-17-hydroxy- 19-norpregna-4,9-diene-3,20-dione 5,6-dimethoxy-2 - (4-pyridyl) methylene-1-indenone (11β)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione Ulipristal (USAN/INN) Intermediate of Ulinastatin Acetate 6J5J15Q2X8 (8S,11R,13S,14S,17R)-17-Acetyl-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-6,7,8,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one Deacetyl CDB 2914 19-Norpregna-4,9-diene-3,20-dione,11-[4-(dimethylamino)pheny 8S,11R,13R,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Ulipristal: (11)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione (11beta)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione 19-Norpregna-4,9-diene-3,20-dione, 11-[4-(dimethylamino)phenyl]-17-hydroxy-, (11β) 19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-, (11β) (8S,11R,13S,14S,17R)-17-Acetyl-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-6,7,8,11,12,1 11β-[4-(N,N-Dimethylamino)-phenyl]-17α-hydroxy-19-norpregna-4,9-diene-3,20-dione (N-1) Ulipristal,11beta-[4-(N,N-diMethylaMino)-phenyl]-17alpha-hydroxy-19-norpregna-4,9-diene-3,20-dione Ulipristal acetate InterMediate 11β-[4-(N,N-Dimethylamino)-phenyl]-17α-hydroxy-19 (11beta)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-19-norpregna-4 11β-[4-(N 19-Norpregna-4,9-diene-3,20-dione,11-[4-(dimethylamino)phenyl]-17-hydroxy-, (11b) 11-(Acetylthio)decanoic Acid-d20 (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(diMethylaMino)phenyl)-1,2, 7,8,11,12,13,15,16,17-decahydro-17-hydroxy-13-Methyl-6H-cyclopenta [a]phenanthren-3(14H)-one 11β-[4-(N,N-Dimethylamino)-Phenyl]-17α-Hydroxy-19-Norpregna 11beta-[4-(N,N-diMethylaMino)-phenyl]-17alpha-hydroxy-19-norpregna-4,9-diene-3,20-dione Ulipristal-008 11β-[4-(N,N-dimethylamino)-phenyl]-17α-hydroxy-19-norpregna-4,9-diene-3,20-dione (8s,11r,13s,14s,17r)-17-acetyl-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-3-one Ulipristal //BP 9-diene-3 Ulipristal [USAN:INN:BAN] Deacetyl CDB |
| Description | Ulipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM). Ulipristal binds to the progesteron receptor, thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Ulipristal (CDB 3236) may suppress the growth of uterine leiomyomatosis. By inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 638.5±55.0 °C at 760 mmHg |
| Melting Point | 183.5-184.5ºC /Losartan/ |
| Molecular Formula | C28H35NO3 |
| Molecular Weight | 433.582 |
| Flash Point | 340.0±31.5 °C |
| Exact Mass | 433.261688 |
| PSA | 57.61000 |
| LogP | 3.86 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.613 |
| Precursor 9 | |
|---|---|
| DownStream 1 | |